Tricyclic benzazepine derivatives as squalene synthase inhibitors used for the treatment of cardiovascular diseases

Details for Australian Patent Application No. 2004313695 (hide)

Owner Bayer HealthCare AG

Inventors Griebenow, Nils; Buchmuller, Anja; Sussmeier, Frank; Weber, Olaf; Raabe, Martin; Harter, Michael; Flessner, Timo; Ellinghaus, Peter; Bischoff, Hilmar; Woltering, Elisabeth; Jeske, Mario; Kolkhof, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2004313695

PCT Pub. Number WO2005/068472

Priority 102004001871.5 14.01.04 DE

Filing date 31 December 2004

Wipo publication date 28 July 2005

International Classifications

A61K 31/553 (2006.01) - having at least one nitrogen and at least one oxygen as ring hetero atoms, e.g. loxapine, staurosporine

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/068472 Priority application(s): WO2005/068472

14 May 2009 Assignment before Grant

  Bayer HealthCare AG The application has been assigned to Bayer Schering Pharma Aktiengesellschaft 2005

28 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004313696-6-amino-5-cyano-pyrimidine-4-ones used for improving perception, power of concentration, learning efficiency, and/ or memory power

2004313694-Production method